Concourse Financial Group Securities, Inc. Adaptive Biotechnologies Corp Transaction History

Concourse Financial Group Securities, Inc.

$1.56 Billion
Q2 2024

Number of Shares

Previous 0 NaN%

Holding current value

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 23, 2024	BUY	$2.34 - $3.96 $0 - $0	0 New	0 $0
Q1 2024 Apr 30, 2024	BUY	$2.88 - $4.8 $0 - $0	0 New	0 $0
Q4 2023 Feb 07, 2024	BUY	$3.46 - $5.33 $0 - $0	0 New	0 $0
Q3 2023 Oct 30, 2023	BUY	$5.07 - $8.44 $0 - $0	0 New	0 $0
Q3 2023 Oct 25, 2023	SELL	$5.07 - $8.44 $1,014 - $1,688	-200 Closed	0 $0
Q4 2022 Jan 30, 2023	BUY	$6.26 - $9.34 $1,252 - $1,868	200 New	200 $0
Q3 2022 Nov 15, 2022	SELL	$6.5 - $12.67 $1,300 - $2,534	-200 Closed	0 $0
Q1 2022 May 09, 2022	SELL	$10.12 - $28.9 $4,979 - $14,218	-492 Reduced 71.1%	200 $3,000
Q4 2021 Feb 07, 2022	BUY	$25.17 - $36.85 $12,182 - $17,835	484 Added 232.69%	692 $19,000
Q2 2021 Aug 13, 2021	SELL	$32.22 - $44.59 $19,332 - $26,754	-600 Reduced 74.26%	208 $8,000
Q1 2021 May 13, 2021	BUY	$37.26 - $67.74 $22,356 - $40,644	600 Added 288.46%	808 $33,000
Q4 2020 Feb 02, 2021	BUY	$45.01 - $65.47 $360 - $523	8 Added 4.0%	208 $12,000
Q3 2019 Nov 13, 2019	BUY	$30.31 - $53.51 $6,062 - $10,702	200 New	200 $6,000
Q2 2019 Aug 13, 2019	BUY	$40.3 - $48.3 $0 - $0	0 New	0 $0

Others Institutions Holding ADPT

# of Institutions

187

Shares Held

152M

Call Options Held

8.4K

Put Options Held

56K

Viking Global Investors LP

30M
Shares

$143 Million
0.43% of portfolio
Rubric Capital Management LP New York, NY

14M
Shares

$66.9 Million
1.5% of portfolio
Black Rock Inc. New York, NY

11.7M
Shares

$55.8 Million
0.0% of portfolio
Matrix Capital Management Company, LP Waltham, MA

11.6M
Shares

$55.3 Million
0.32% of portfolio
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

11.4M
Shares

$54.5 Million
0.38% of portfolio

View Full List

About Adaptive Biotechnologies Corp

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $683M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

More about ADPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account